Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Ivan Buzurovic, Ph.D.

Concepts (140)

Back to Profile
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Brachytherapy28202312384.800 Why?
Radiotherapy, Computer-Assisted52013901.640 Why?
Film Dosimetry42020291.580 Why?
Radiotherapy Planning, Computer-Assisted17202316601.350 Why?
Radiotherapy Dosage19202328971.130 Why?
Robotics620138741.050 Why?
Needles520224510.910 Why?
Radiometry920208130.890 Why?
Catheters520234250.760 Why?
Radiotherapy, Conformal220135490.620 Why?
Genital Neoplasms, Female120235330.580 Why?
Uterine Cervical Neoplasms4202120030.500 Why?
Transistors, Electronic12013210.430 Why?
Telemetry120131990.390 Why?
Endometrial Neoplasms4202213570.380 Why?
Skin Diseases1202010890.370 Why?
Beds12011480.370 Why?
Prostatic Neoplasms112021113450.340 Why?
Movement3201214740.310 Why?
Patient Positioning120113270.300 Why?
Phantoms, Imaging4202225120.280 Why?
Prostheses and Implants1201312730.260 Why?
Radiation Oncology220235630.250 Why?
Equipment Failure Analysis320138480.220 Why?
Equipment Design4202135200.220 Why?
Calibration320208160.200 Why?
Vaginal Neoplasms120211040.180 Why?
Feasibility Studies2202152010.160 Why?
Dose-Response Relationship, Radiation220178810.150 Why?
DNA Mismatch Repair120214290.150 Why?
Automation120205800.140 Why?
Carcinoma, Endometrioid120192760.140 Why?
Carcinoma, Adenosquamous12016660.130 Why?
Software Validation12014590.120 Why?
Neoplasms32017220720.120 Why?
Carcinoma, Basal Cell120195590.120 Why?
Photons220155810.110 Why?
Carcinoma, Squamous Cell2201940240.100 Why?
Monte Carlo Method2201712570.100 Why?
Androgen Antagonists2201714420.100 Why?
Pennsylvania120136150.100 Why?
Catheters, Indwelling120144280.100 Why?
Swine1202158990.100 Why?
Mechanical Phenomena120121400.100 Why?
Magnetic Resonance Spectroscopy1202137650.090 Why?
Models, Theoretical2201735620.090 Why?
Radiotherapy1201715040.090 Why?
Skin Neoplasms3201957990.090 Why?
Humans2920237606210.090 Why?
Computer Systems120124700.090 Why?
Reproducibility of Results62015200800.090 Why?
Neoplasm Recurrence, Local5202292760.090 Why?
Ultrasonography2201459610.090 Why?
Tomography, X-Ray Computed42021205090.090 Why?
Linear Models1201958770.080 Why?
Academic Medical Centers2201627540.080 Why?
Magnetic Resonance Imaging32023362900.080 Why?
Prostate4202117930.080 Why?
Uterine Neoplasms1201714390.080 Why?
Evidence-Based Medicine1201936960.070 Why?
Dose-Response Relationship, Drug12019108270.070 Why?
Sensitivity and Specificity22013146600.070 Why?
Quality Assurance, Health Care2201521760.070 Why?
Lung Neoplasms12011132620.070 Why?
Radiotherapy, Intensity-Modulated120128010.060 Why?
Utilization Review220163830.060 Why?
Radiotherapy, Adjuvant2202017910.060 Why?
Female1120233912700.060 Why?
Health Physics12023300.050 Why?
Survival Analysis32021101820.050 Why?
Societies120231080.050 Why?
Prosthesis Implantation120075940.050 Why?
Retrospective Studies92022803720.050 Why?
Chemotherapy, Adjuvant2202035290.040 Why?
Carcinosarcoma120201040.040 Why?
Adenocarcinoma1201663150.040 Why?
Image Interpretation, Computer-Assisted1201233400.040 Why?
Surgery, Computer-Assisted1200710080.040 Why?
Adenocarcinoma, Clear Cell120202170.040 Why?
Male1120213597440.040 Why?
Research Report120203700.040 Why?
Prospective Studies12021543030.030 Why?
Algorithms22021139810.030 Why?
Time Factors32016401650.030 Why?
Colon, Sigmoid120171240.030 Why?
Societies, Medical2201939050.030 Why?
Patient Selection2201942830.030 Why?
Internship and Residency1201658700.030 Why?
Biopsy, Needle1202116300.030 Why?
Cystadenocarcinoma, Serous120204790.030 Why?
Neoplasm Staging22021111520.030 Why?
Combined Modality Therapy2201785520.030 Why?
Aged820211691520.030 Why?
Salvage Therapy1202212680.030 Why?
Organs at Risk120173580.030 Why?
Antineoplastic Agents12017136300.030 Why?
Color120152980.030 Why?
Aged, 80 and over42021589950.030 Why?
Scattering, Radiation120154880.030 Why?
Treatment Outcome52020650170.030 Why?
Particle Accelerators120131740.030 Why?
Materials Testing120158620.030 Why?
Rectum120178950.020 Why?
SEER Program1201715300.020 Why?
Middle Aged720212203520.020 Why?
United States42023724610.020 Why?
Water1201714070.020 Why?
Canada1201621280.020 Why?
Uncertainty120157540.020 Why?
Urinary Bladder1201711660.020 Why?
Tumor Burden1201618950.020 Why?
Watchful Waiting120145100.020 Why?
Light1201513440.020 Why?
Propensity Score1201719280.020 Why?
Animals120211679630.020 Why?
Biopsy1202167710.020 Why?
Temperature1201522210.020 Why?
Radiation Dosage1201719580.020 Why?
Cone-Beam Computed Tomography120124710.020 Why?
Probability1201324750.020 Why?
Adult520212199940.020 Why?
Antineoplastic Combined Chemotherapy Protocols22020117120.020 Why?
Micromanipulation12007520.020 Why?
Prostate-Specific Antigen1201625290.020 Why?
Disease-Free Survival1201668280.020 Why?
Survival Rate12020128080.020 Why?
Kaplan-Meier Estimate1201665440.020 Why?
Ultrasonography, Interventional1201415020.020 Why?
Medical Oncology1201723130.020 Why?
Databases, Factual1201780350.010 Why?
Models, Statistical1201550750.010 Why?
Cohort Studies12020413350.010 Why?
Imaging, Three-Dimensional1201140480.010 Why?
Prognosis12017296580.010 Why?
Computer Simulation1200762180.010 Why?
Breast Neoplasms12017210250.010 Why?
Young Adult12016587410.010 Why?
Adolescent12016878100.000 Why?
Risk Assessment12007241230.000 Why?
Risk Factors12007743590.000 Why?
Buzurovic's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (140)
Explore
_
Co-Authors (37)
Explore
_
Similar People (60)
Explore
_
Same Department 
Explore
_
© 2024 President and Fellows of Harvard College
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.